Nebulized dexmedetomidine for early chronic migraine
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether a medicine called dexmedetomidine, given through a nebulizer (mist you breathe in), can help reduce the number of headache days and prevent migraines from becoming chronic. It is for people who have recently started having many headache days each month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had migraine with 15 or more headache days per month for less than 6 months.
- You have not taken any migraine prevention medication in the last 8 weeks.
- You do not have heart, lung, psychiatric, or other neurological conditions.
- You are not currently taking sedatives, opioids, or CGRP-targeting therapies.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an add-on migraine medicine (eptinezumab) given in the emergency room to quickly relieve a migraine attack, in addition to the usual care. It aims to see if this approach reduces pain and prevents the migraine from coming back.
This trial tests whether a single injection of dexmedetomidine into the knee joint can reduce chronic knee pain. It is for people who are not scheduled for knee surgery and have no serious health problems.
This study tests whether giving two pain-relieving medicines, ketamine and lidocaine, through an IV can help adults with chronic migraine that hasn't improved with other treatments. The goal is to see if this treatment reduces migraine pain and improves daily life.
This trial tests if a medication called dexmedetomidine (given as a mist through a nebulizer) can help keep your heart rate and blood pressure steady when a breathing tube is placed for surgery. It may be an option for people having planned surgery who want a smoother experience.
This trial tests whether an IV dose of ketamine can reduce chronic daily headaches and is safe for people with this condition. It may help by lowering headache frequency and severity, but it also has several medicine and health-related safety checks.
This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.
Hear when a new Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.